Glodkowska-Mrowka et al. suggested that statins increased the intracellular concentrations of IM in primary CML cells and cell lines through the inhibition of the membrane efflux transporters ABCB1 and ABCG2 [45]. This evidence concerns the gene ABCG2 and chronic myelogenous leukemia, BCR-ABL1 positive.